Vytrus Biotech, S.A. (BME:VYT)
3.300
0.00 (0.00%)
At close: May 9, 2025, 5:30 PM CET
Vytrus Biotech Revenue
Vytrus Biotech had revenue of 3.03M EUR in the half year ending June 30, 2024, with 26.54% growth. This brings the company's revenue in the last twelve months to 5.24M, up 14.24% year-over-year. In the year 2023, Vytrus Biotech had annual revenue of 4.70M with 4.90% growth.
Revenue (ttm)
5.24M
Revenue Growth
+14.24%
P/S Ratio
4.75
Revenue / Employee
149.64K
Employees
35
Market Cap
24.88M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grifols | 7.21B |
Laboratorios Farmaceuticos Rovi | 767.47M |
Almirall | 990.63M |
Faes Farma | 524.02M |
Pharma Mar | 175.75M |
Clínica Baviera | 265.72M |
Laboratorio Reig Jofre | 338.90M |
Atrys Health | 218.10M |